ResMed Inc. has agreed to sell its MatrixCare software business to Frazier Healthcare Partners in an all-cash transaction valued at $490 million. The transaction is expected to close in the first quarter of ResMed's fiscal year 2027, subject to required regulatory approvals and customary closing conditions.

MatrixCare is a leading provider of electronic health record (EHR) and care management software for post-acute and long-term care providers. The business serves more than 15,000 healthcare providers across skilled nursing facilities, senior living communities, home health agencies, hospice providers, and other long-term care settings.

For ResMed, the MatrixCare divestiture represents a significant portfolio simplification. ResMed acquired MatrixCare in 2018 for approximately $750 million as part of a strategy to expand into software-enabled care management for post-acute care settings. The acquisition was intended to complement ResMed's core respiratory care business by providing software infrastructure for the care settings where many ResMed patients receive treatment.

The decision to divest MatrixCare reflects a strategic refocusing on ResMed's core competencies: sleep health (CPAP and related devices and software), breathing health (ventilation and respiratory care), and connected home-based healthcare. The $490 million proceeds will be redeployed into these core areas — including continued investment in ResMed's AirView and myAir digital health platforms.

The transaction also reflects the broader trend of medical device and healthcare companies rationalizing software portfolios acquired during the digital health investment cycle of the late 2010s, as the integration challenges and capital requirements of maintaining enterprise healthcare software businesses have proven more demanding than anticipated.

For Frazier Healthcare Partners, a healthcare-focused private equity firm, MatrixCare represents a platform acquisition in the post-acute care software market. The post-acute care sector — skilled nursing, home health, hospice, and senior living — is undergoing significant consolidation and technology adoption pressure, driven by:

• Value-based care models that require more sophisticated data capture and reporting
• Regulatory requirements for interoperability and electronic health record adoption
• Workforce management challenges that create demand for software-enabled efficiency
• Payer pressure on post-acute care providers to demonstrate outcomes and reduce readmissions

MatrixCare's installed base of more than 15,000 providers gives Frazier a significant market position from which to pursue organic growth and add-on acquisitions in the post-acute care software space.

The MatrixCare transaction is a carve-out — the separation of a software business from a larger corporate parent. Healthcare IT carve-outs present distinctive challenges:

Data Separation MatrixCare's systems contain protected health information (PHI) for patients of its provider customers. The carve-out requires careful planning for how patient data will be handled during the transition — ensuring that PHI is not commingled with ResMed's retained systems and that appropriate data governance structures are in place from day one of standalone operation.

System Separation MatrixCare likely shares IT infrastructure, security systems, and enterprise software (ERP, HR, finance) with ResMed. The carve-out requires a detailed technology separation plan, typically implemented through a transition services agreement (TSA) under which ResMed continues to provide certain IT and back-office services to MatrixCare for a defined period post-closing.

HIPAA Business Associate Agreements MatrixCare operates as a business associate under HIPAA — it processes PHI on behalf of covered entity healthcare providers. The change of ownership requires review and, where necessary, amendment of business associate agreements (BAAs) with MatrixCare's provider customers. Frazier and MatrixCare will need to ensure that BAA coverage is continuous through the ownership transition.

MatrixCare's revenue is derived from long-term software contracts with healthcare providers. Many of these contracts will contain:

• Assignment restrictions: Provisions requiring customer consent to assignment of the contract in connection with a change of control
• Termination rights: Rights allowing customers to terminate the contract upon a change of control
• Most-favored-nation provisions: Pricing protections that may be triggered by the transaction

The due diligence process will have required a detailed review of MatrixCare's customer contract portfolio to identify contracts requiring consent, assess termination risk, and develop a customer communication and consent strategy.

Healthcare EHR software involves complex intellectual property considerations:

• Open-source software: EHR systems typically incorporate open-source components; the due diligence process requires a software composition analysis to identify open-source licenses that may impose obligations on the acquirer
• Third-party licenses: MatrixCare's software likely incorporates licensed third-party components; the change of ownership may require consent from or notification to licensors
• Interoperability interfaces: Healthcare software must interface with other systems (hospital EHRs, payer systems, pharmacy systems) through standardized interfaces; the acquirer must ensure continuity of these interfaces post-closing

The transaction is subject to required regulatory approvals. In the healthcare IT sector, the primary regulatory consideration is typically Hart-Scott-Rodino (HSR) antitrust review. Given MatrixCare's market position in post-acute care software, the parties will have assessed whether the transaction raises horizontal competition concerns.

Healthcare-specific regulatory considerations — such as state healthcare facility licensing requirements that may be triggered by a change of ownership of a software vendor — should also be reviewed.

The TSA is a critical document in any carve-out transaction. For the MatrixCare transaction, the TSA will likely cover:

• IT infrastructure and security services during the separation period
• Finance and accounting services
• HR and payroll services
• Legal and compliance support
• Customer support infrastructure

The duration and scope of TSA services, the pricing of those services, and the exit rights and penalties for early termination are heavily negotiated. Healthcare IT carve-outs typically require longer TSA periods than other software carve-outs because of the complexity of separating healthcare data systems and the regulatory requirements for continuity of service to healthcare provider customers.

The MatrixCare transaction is part of a broader consolidation trend in post-acute care software. The post-acute care market is fragmented, with multiple EHR vendors serving different segments (skilled nursing, home health, hospice, senior living). Private equity firms have been active acquirers in this space, seeking to build integrated platforms that can serve providers across the care continuum.

Key competitors in the post-acute care EHR market include PointClickCare (backed by Hellman & Friedman), WellSky (backed by TPG), and Netsmart Technologies (backed by GI Partners). The MatrixCare acquisition by Frazier positions it as a significant player in this competitive landscape.

The ResMed-MatrixCare transaction is a significant healthcare IT carve-out with implications across multiple legal and compliance dimensions — HIPAA data governance, customer contract assignment, software IP, transition services, and PE-backed healthcare software consolidation. For healthcare providers using MatrixCare software, the transaction signals a change of ownership that warrants review of existing contracts and BAAs. For competitors and investors in the post-acute care software market, the transaction reinforces the ongoing consolidation dynamic in this sector.